Cedarburg Pharma can help you successfully manage a wide range of pharmaceutical development projects.
Cedarburg Pharmaceuticals, a division of Albany Molecular Research Inc. has the flexibility and experience to offer you anything from complete API development services to specialty services addressing a very specific need.
Our analytical services support the development & manufacturing of your API.
Our “GMP Continuum” approach to quality provides customers with a unique quality system tailored to meet their needs.
Our experienced regulatory staff provides support for your regulatory filings, helping guide you through the complexities of the FDA submission process.
Our unique centralized project management system has yielded >90% on-time and on-budget performance.
Events Cedarburg Pharma is attending in 2014.
CPhI World Wide – Paris, France
See what’s happening at Cedarburg Pharmaceuticals.
- March 24, 2014: Cedarburg Pharmaceuticals to be Acquired by Albany Molecular Research, Inc.
- February 11, 2014: Alex Tretyakov Hired as Director of Process Development
- September 18, 2013: Cedarburg Hauser Upgrades API Manufacturing Plant
- August 8, 2013: Cedarburg Hauser receives CMO Leadership Award